These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 12820313
1. Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening. Hardt PD, Toepler M, Ngoumou B, Rupp J, Kloer HU. Anticancer Res; 2003; 23(2A):855-7. PubMed ID: 12820313 [Abstract] [Full Text] [Related]
2. Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls. Hardt PD, Toepler M, Ngoumou B, Rupp J, Kloer HU. Anticancer Res; 2003; 23(2A):851-3. PubMed ID: 12820312 [Abstract] [Full Text] [Related]
9. [Comparison of different stool tests for the detection of cancer of the colon]. Vogel T, Driemel C, Hauser A, Hansmann A, Lange S, Jonas M, Möslein G. Dtsch Med Wochenschr; 2005 Apr 08; 130(14):872-7. PubMed ID: 15800820 [Abstract] [Full Text] [Related]
10. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures. Elia S, Massoud R, Guggino G, Cristino B, Cortese C, De Massimi AR, Zenobi R. Eur J Cardiothorac Surg; 2008 Apr 08; 33(4):723-7. PubMed ID: 18261916 [Abstract] [Full Text] [Related]
20. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease. Czub E, Herzig KH, Szaflarska-Popawska A, Kiehne K, Socha P, Woś H, Kamińska B, Błaszczyński M, Cichy W, Bała G, Brodzicki J, Grzybowska-Chlebowczyk U, Walkowiak J. Scand J Gastroenterol; 2007 Oct 08; 42(10):1147-50. PubMed ID: 17852864 [Abstract] [Full Text] [Related] Page: [Next] [New Search]